Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

3D printing is a manufacturing game-changer

Calling all carnivores: ever thought about getting a meat printer? Of hand-crafting delectable beef steaks at home from plant proteins, that have the same texture, appearance and flavor as real meat, only without the distasteful killing part? 3D-printed steaks and chicken ...
Richard (Rick) Mills | November 15, 2019 |

Should You Buy the Panic?

If anyone has the right to say “I told you so,” it’s Bill Gates. Two years ago, the co-founder, former CEO and now former board member of Microsoft urged governments to step up their preparedness in the event of a modern global ...
Frank Holmes | March 16, 2020 |

Anixa Licenses Another Potential Blockbuster

In January we proclaimed Anixa Biosciences Inc. (ANIX:NASDAQ) to be Tailwinds' stock of the year. This designation was awarded due to potential major milestones in both the detection and the curing of cancer. With its Cchek prostate diagnostic shooting for CLIA approval...
Streetwise Reports | July 25, 2019 |

Why Provention Bio Is in My Portfolio

Quite often when I write about companies I'm just about the only one doing so. It's in these situations that Tailwinds can add value by not only highlighting our investment thesis, but in educating investors about a company for which there is little to no publicly avail...
Streetwise Reports | August 26, 2019 |

Natural Gas Moves Into Basing Zone

After an incredible rally in Natural Gas that our researchers called perfectly in November 2018, another opportunity for an upside price move appears to be setting up for later this year. We believe the current price lows, near $2.30, are setting up for a bounce and then will ...
Chris Vermeulen | June 11, 2019 |

Last one standing: The most undervalued lithium stock?

Why this company could be the next big lithium buyout (Source: Lithium South Development Corp.) By Carlise Kane of The Equedia Letter Records are meant to be broken – but not this badly. After a record-breaking 2022, THIS industry is on...
Research | September 13, 2023 |

Sector Rotation Giving Mixed Signals About The Future

It seemed the markets wanted to make a point to alert us that volatility may be here to stay very early in trading this week. After a fairly flat overnight session with very little price volatility, the markets opened up to a moderately large price rotation (first downward, th...
Chris Vermeulen | September 9, 2019 |

Is Natural Gas Ready For An April Rally?

Our researchers have been following Natural Gas for many months and believe the current price level, near $1.65, is acting as a continued historical support level (a floor in price). Our researchers also used one of our data mining tools to attempt to identify if any opportu...
Chris Vermeulen | April 7, 2020 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |

Gold not in Real Bull Market Yet

Is Gold now back in a bull market? Most gold bugs think so and are quick to proclaim that. But, could Gold remain in a secular bear market? It hasn’t made a new all time high in 8 years and the perma-bull, financial asset loving crowd certainly believes so....
Jordan Roy-Byrne, CMT | September 25, 2019 |
1 2 3 4 5 6 7 8 9 10 ...